| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/19/2007 | CA2636914A1 Oral composition containing interferon-.alpha. |
| 07/19/2007 | CA2636706A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration |
| 07/19/2007 | CA2636633A1 Ace n-domain crystal |
| 07/19/2007 | CA2636533A1 Use of tpp ii inhibitors in combination with gamma-irradiation for the treatment of cancer |
| 07/19/2007 | CA2636469A1 Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
| 07/19/2007 | CA2636088A1 Small-volume oral transmucosal dosage forms |
| 07/19/2007 | CA2635996A1 Methods and compositions for treating asthma in human and non human primates |
| 07/19/2007 | CA2635616A1 Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
| 07/19/2007 | CA2634329A1 Octanoate-reduced human albumin |
| 07/19/2007 | CA2633674A1 Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| 07/19/2007 | CA2633324A1 Thrombin-free biological adhesive and use thereof as a medicament |
| 07/18/2007 | EP1808489A1 Expression system for Bacillus anthracis PA |
| 07/18/2007 | EP1808444A1 Amyloid beta protein (globular assembly and usees thereof) |
| 07/18/2007 | EP1808440A1 Non-covalent inhibitors of urokinase and blood vessel formation |
| 07/18/2007 | EP1808439A2 Epiligrin, an epithelial ligand for integrins |
| 07/18/2007 | EP1808438A2 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/18/2007 | EP1808184A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 07/18/2007 | EP1808180A2 Modified GP 100 and uses thereof |
| 07/18/2007 | EP1808179A2 Use of HSP20 for promoting wound healing and/or reducing scar formation |
| 07/18/2007 | EP1808160A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/18/2007 | EP1808158A2 Presbyopia treatment by lens alteration |
| 07/18/2007 | EP1807517A1 Bacterial vector |
| 07/18/2007 | EP1807108A2 Methods for the treatment and prevention of diseases of biological conduits |
| 07/18/2007 | EP1807107A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 07/18/2007 | EP1807106A2 Compositions and methods for treating disease |
| 07/18/2007 | EP1807105A2 Insulin receptor binding peptides with non-insulin gene activation profiles and uses thereof |
| 07/18/2007 | EP1807104A1 Botulinum toxin therapy of heart rhythm disorders |
| 07/18/2007 | EP1807103A2 Modulators of retinol-retinol binding protein (rbp)-transthyretin (ttr) complex formation |
| 07/18/2007 | EP1807102A2 Compositions and methods for the treatment of obesity and sexual dysfunction |
| 07/18/2007 | EP1807101A2 Devices and methods for integrated continuous manufacturing of biological molecules |
| 07/18/2007 | EP1807099A2 Y2 selective receptor agonists for therapeutic interventions |
| 07/18/2007 | EP1807065A2 Methods and compositions for treating nephrogenic diabetes insipidus |
| 07/18/2007 | EP1807049A1 Spontaneously dispersible pharmaceutical compositions |
| 07/18/2007 | EP1806983A1 Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal |
| 07/18/2007 | EP1558747A4 Glycoprotein synthesis |
| 07/18/2007 | EP1497436B1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 07/18/2007 | EP1372702B1 Treatment of hypoxia/ischaemia related blood flow resistance using beta-interferon |
| 07/18/2007 | EP1285002B1 Regulating lipid levels via the zmax1 or hbm gene |
| 07/18/2007 | EP1181043B1 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 07/18/2007 | EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/18/2007 | EP1139753B1 Formulations for treating disease and methods of using same |
| 07/18/2007 | EP1098905B1 Rna helicases modulating translation termination |
| 07/18/2007 | EP0860447B1 Hematopoietic stem cell growth factor (scgf) |
| 07/18/2007 | EP0770140B1 Composition containing nucleic acids and cationic polymers, preparation and uses |
| 07/18/2007 | CN1326997C OMPA gene for outer membrane protein of riemerella anatipestifer and methods of use |
| 07/18/2007 | CN1326929C The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use |
| 07/18/2007 | CN1326882C Carcino-embryonic untigen specific combined peptide and fusion protein with TNF-alpha |
| 07/18/2007 | CN1326880C G-CSF receptor agonist antibodies and screening method therefor |
| 07/18/2007 | CN1326876C Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/18/2007 | CN1326875C Tumor antigen protein and tumor antigen peptide |
| 07/18/2007 | CN1326872C Method for preparing echinocandin derivatives |
| 07/18/2007 | CN1326870C Antibacterial amide macrocycles |
| 07/18/2007 | CN1326566C Immunotherapeutic combinations for the treatment of tumors |
| 07/18/2007 | CN1326565C Potentiator for antibody against lymphoid tumor |
| 07/18/2007 | CN1326563C Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 07/18/2007 | CN1326562C Use of IL-18 inhibitors for treatment and/or prevention of heart disease |
| 07/18/2007 | CN1326561C Remedies for liver diseases, hyperlipemia and diabetes |
| 07/18/2007 | CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy |
| 07/18/2007 | CN1326559C Chinese herbal medicine oral liquid for face nourishing antidebilitation and its preparation method |
| 07/18/2007 | CN1326558C Chinese herbal medicine oral liquid for treating high blood pressure and its preparation method |
| 07/18/2007 | CN101001870A Peptid-baserte forbindelser |
| 07/18/2007 | CN101001868A Epitope analogs |
| 07/18/2007 | CN101001670A Compositions for sleeping disorders |
| 07/18/2007 | CN101001644A Uses of spatial configuration to modulate protein function |
| 07/18/2007 | CN101001643A CCR ligands for stem cell homing |
| 07/18/2007 | CN101001642A Combination therapy for diabetes, obesity, and cardiovascular diseases using GDF-8 inhibitors |
| 07/18/2007 | CN101001641A Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases |
| 07/18/2007 | CN101001640A 缓释组合物 Sustained release composition |
| 07/18/2007 | CN101001639A Pegylation of vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase activating peptide (PACAP) receptor 2 (VPAC2) agonists and methods of use |
| 07/18/2007 | CN101001638A Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 07/18/2007 | CN101001620A Use of alpha-ketoglutarate and related compounds for lowering plasma lipids |
| 07/18/2007 | CN100999752A Antioxydizing peptide mixture from collagen and its preparation process and use |
| 07/18/2007 | CN100999737A Trichina paramyosin gene and application thereof |
| 07/18/2007 | CN100999727A Tumor and immune related regulating and controlling gene caspase-10/G |
| 07/18/2007 | CN100999725A Cell periodic important regulating and controlling kinase PFTK1 |
| 07/18/2007 | CN100999553A IIR2 analogous protein and its coding gene and application |
| 07/18/2007 | CN100999552A Liver target fusion protein with siRNA guiding effect |
| 07/18/2007 | CN100999550A Tubercle branch bacillus fusion protein and application thereof |
| 07/18/2007 | CN100999547A Protein polypeptide of anti new vasoformation and application thereof |
| 07/18/2007 | CN100999546A Polypeptide compound with aza-containing heterocyclic modified and its application |
| 07/18/2007 | CN100998872A Polypeptide medicine intercalation hydrotalcite and its preparation method |
| 07/18/2007 | CN100998869A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998865A Modicine and food dual-purpose composition using forest frog active peptide component as active constituent and its use |
| 07/18/2007 | CN100998864A Cyclosporin A semisolid skeleton capsule and its preparation method |
| 07/18/2007 | CN100998863A N-acetyl carnosine eye drops for preventing and treating cataract and its preparation method |
| 07/18/2007 | CN100998862A Ossotide glucose injection |
| 07/18/2007 | CN100998861A Cerebroprotein hydrolysate sodium chloride injection |
| 07/18/2007 | CN100998860A Troxerutin cerebroprotein hydrolysate sodium chloride injection liquid |
| 07/18/2007 | CN100998789A Powder medicine for strengthening body resistance and removing turbid qi |
| 07/18/2007 | CN100998607A Injecta containing compound bone peptide and sodium chloride |
| 07/18/2007 | CN100998565A Anti-angiogene compositions and methods of use |
| 07/17/2007 | US7244833 Yeast expressed with cell proliferation stimulatory factor; hematological disorders |
| 07/17/2007 | US7244832 host cell tranformed with a nucleic acid encoding an antibody having a composite heavy chain with a variable domain including complementarity determining regions and framework regions comprising human acceptor antibody heavy chain framework region residues |
| 07/17/2007 | US7244827 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 07/17/2007 | US7244826 May have a cytotoxin, a label, a radionuclide, a drug, a liposome, a ligand, or an antibody effector attached to the antibody |
| 07/17/2007 | US7244825 Vial containing a dried native Factor VIII composition containing trehalose as a stabilizer and no albumin; may be reconstituted with water or brine for administration to a hemophilic patient by injection; stable at up to 60 degrees C. |
| 07/17/2007 | US7244824 Blood-coagulation factor VIII (or antihemophilic factor) containing trehalose stabilizer in absence of albumin; reconstitution with water |
| 07/17/2007 | US7244823 Treating autoimmune diseases |
| 07/17/2007 | US7244821 Expression vector comprising nucleotide sequences coding glucose transport protein 4 ( GLUT4) for identifying modulator for prevention and treatment of diabetes |
| 07/17/2007 | US7244819 Fusion polypeptides, vaccines and compositions of FKBP chaperones and target polypeptides |